CRISPR THERAPEUTICS AG (CRSP) Capital expenditures 2016–2025
CRISPR THERAPEUTICS AG (CRSP) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$914,000FY2025 · since FY2016: $3.0M → $914,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $914,000 | -51.9% |
| FY2024 | $1.9M | -79.9% |
| FY2023 | $9.5M | -74.5% |
| FY2022 | $37.2M | -54.5% |
| FY2021 | $81.7M | +345.1% |
| FY2020 | $18.4M | +174.7% |
| FY2019 | $6.7M | +141.0% |
| FY2018 | $2.8M | -64.5% |
| FY2017 | $7.8M | +159.1% |
| FY2016 | $3.0M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice